HPV Clinical Trials
Find clinical trials for HPV. Search for HPV clinical trials in different cities and states across the United States.
HB-202/HB-201A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)
Sponsor:
Memorial Sloan Kettering Cancer Center
Location:
Code:
NCT06373380
Conditions
HPV16+ Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
HB-200
CemiplimabTrial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Location:
Code:
NCT04988074
Conditions
HPV-Related Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cemiplimab
Surgical Resection with IMRTTransoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Sponsor:
Heath Skinner
Location:
Code:
NCT05388773
Conditions
Oropharynx Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
therapeutic conventional surgery
laboratory biomarker analysis
quality-of-life assessment
intensity-modulated radiation therapy
Cisplatin
Observational StudyClinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT05046080
Conditions
Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type
Eligibility Criteria
Sex: Female
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Electronic Health Record Review
Laboratory Biomarker Analysis
PDS0101 & PembrolizumabPhase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Sponsor:
PDS Biotechnology Corp.
Location:
Code:
NCT06790966
Conditions
Recurrent Head and Neck Cancer
Metastatic Head and Neck Cancer
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Neoplasms, Head and Neck
Unresectable Head and Neck Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Combination Treatment of PDS0101 and Pembrolizumab
Pembrolizumab Monotherapy
Pembrolizumab & OlaparibPembrolizumab Plus Olaparib in LA-HNSCC
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Location:
Code:
NCT05366166
Conditions
Squamous Cell Carcinoma of Head and Neck
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Olaparib
Cisplatin
IMRT (intensity modulated radiation therapy)
E7 TCR-T Cell ImmunotherapyE7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Sponsor:
Christian Hinrichs
Location:
Code:
NCT05686226
Conditions
Cervical Cancer
Throat Cancer
Oropharynx Cancer
Anal Cancer
Vulva Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
E7 TCR-T cells
Aldesleukin
STAR0602A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants with Advanced Solid Tumors
Sponsor:
Marengo Therapeutics, Inc.
Location:
Code:
NCT05592626
Conditions
Advanced Solid Tumors
Genital Neoplasm, Female
Urogenital Neoplasms
Lung Neoplasm
Neoplasms by Site
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
STAR0602
Radiotherapy with ctDNAAdaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
Sponsor:
Ohio State University Comprehensive Cancer Center
Location:
Code:
NCT06323460
Conditions
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC V8
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC V8
Oropharyngeal Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Carboplatin
Cisplatin
Computed Tomography
External Beam Radiation Therapy